Xylem (XYL) Stock Forecast & Price Target

$133.47

-1.56 (-1.16%)

(As of 11:09 AM ET)

Xylem - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
4

Buy
10

Based on 14 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for XYL.

Consensus Price Target

$147.54
9.26% Upside

According to the 14 analysts' twelve-month price targets for Xylem, the average price target is $147.54. The highest price target for XYL is $172.00, while the lowest price target for XYL is $120.00. The average price target represents a forecasted upside of 9.26% from the current price of $133.47.

Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

XYL Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)	8 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$147.54	$147.54	$142.92	$118.54
Forecasted Upside	9.26% Upside	7.28% Upside	7.72% Upside	29.10% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

Shedding light on a dark secret (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Xylem Stock vs. The Competition

Type	Xylem	Industrial Products Companies	S&P 500
Consensus Rating Score	2.71	2.57	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	9.26% Upside	47.51% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent XYL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/3/2024	TD Cowen 4 of 5 stars	J. Giordano Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$138.00	+0.34%
8/13/2024	UBS Group 4 of 5 stars	D. Karas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$165.00	+29.41%
7/31/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Buy ➝ Buy	$170.00 ➝ $172.00	+28.04%
7/31/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$155.00 ➝ $170.00	+26.55%
7/31/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$160.00 ➝ $163.00	+21.05%
5/31/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$147.00 ➝ $152.00	+9.71%
Get the Latest News and Ratings for XYL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter.
5/29/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Eade Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$146.00 ➝ $165.00	+19.75%
5/3/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$110.00 ➝ $135.00	-0.73%
4/8/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$126.00 ➝ $139.00	+8.81%
3/12/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$150.00	+18.88%
1/4/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Market Perform
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$127.00	+17.66%
11/21/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$104.00 ➝ $120.00	+19.74%
10/2/2023	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$122.00	+33.46%
8/29/2023	Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Graham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral
6/29/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates
2/14/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph C Giordano Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform	$115.00 ➝ $120.00	+11.99%
1/18/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$105.00 ➝ $115.00	-0.86%
11/16/2022	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$110.00 ➝ $129.00	+15.05%
11/3/2022	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$85.00 ➝ $95.00	-11.78%
11/2/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$105.00 ➝ $115.00	+7.35%
11/2/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$93.00 ➝ $110.00	+4.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:30 AM ET.

Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

Here are some ways that investors could benefit from investing in Xylem Inc.:

Xylem Inc. has consistently shown strong revenue growth, with a 26.0% increase in revenue reported in the latest quarter, indicating a healthy financial performance.
The company has a moderate buy rating from analysts, with a consensus price target of $147.54, suggesting potential for stock price appreciation.
Xylem Inc. announced a quarterly dividend of $0.36 per share, providing investors with a steady income stream and a dividend yield of 1.08%.
The company's return on equity stands at 9.48%, indicating efficient utilization of shareholder equity to generate profits.
Xylem Inc. operates in the water infrastructure sector, which is essential and resilient, offering stability and long-term growth potential.

Xylem
Bear Case

Investors should be bearish about investing in Xylem Inc. for these reasons:

Xylem Inc.'s stock price has been relatively stagnant, trading at $134.81 as of the latest data, potentially indicating limited short-term capital appreciation.
The company's price-to-earnings ratio of 47.84 is higher than the industry average, suggesting the stock may be overvalued compared to its earnings potential.
Xylem Inc. has a debt-to-equity ratio of 0.19, which although relatively low, indicates some level of financial leverage that could pose risks in economic downturns.
The company's PEG ratio of 2.34 may indicate that the stock is currently overvalued relative to its expected earnings growth rate.
While Xylem Inc. has a strong market capitalization of $32.74 billion, the company operates in a competitive industry with evolving technological advancements that could impact its market position.

XYL Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $147.54, with a high forecast of $172.00 and a low forecast of $120.00.
: 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" XYL shares.
: According to analysts, Xylem's stock has a predicted upside of 10.54% based on their 12-month stock forecasts.
: Xylem has been rated by research analysts at Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, and UBS Group in the past 90 days.
: Analysts like Xylem more than other "industrial products" companies. The consensus rating score for Xylem is 2.71 while the average consensus rating score for "industrial products" companies is 2.57. Learn more on how XYL compares to other companies.